Consensus
The community sees this as unlikely for Sanofi at 38%, based on 7 forecasts. Forecasters are in moderate agreement.
Resolves YES if Sanofi is up more than 14% 90 days out versus its baseline price.
Share your read on this question — the best forecasters show their work.
See the whole sny discussion →